Sunday, 22nd May 2022
<To guardian.ng
Search

AstraZeneca COVID vaccine up to 90% effective, data shows

By Reuters
30 November 2020   |   3:19 pm
Though the late-stage trial results showed an efficacy of 70% on average, up to 90% of people can be prevented from getting the coronavirus if a lower dose is used. AstraZeneca said the vaccine is "highly effective."

Related

22 Dec
Christmas in Bethlehem is usually a festive and colorful season. This year, festivities in the Palestinian town are set to return — but the COVID pandemic is still casting a shadow on the celebrations.
22 Dec
German doctors and their staff have been facing aggression and threats from vaccine opponents. They have described having frayed nerves as pandemic fatigue sets in among patients and medical staff.
26 Dec
With Europe still grappling with Covid-19, Talking Europe speaks to Christa Schweng, President of the European Economic and Social Committee (EESC).
23 Dec
The ambitious goal to fully vaccinate the entire adult population is proving difficult. People are not returning to receive their second dose, and motivating them poses complex challenges.
23 Dec
Find these stories and much more when you grab a copy of The Guardian on Thursday.⁣
25 Dec
At least one officer was injured and 11 demonstrators were arrested in an unofficial rally in Munich as police described the behavior of protesters as "aggressive."
25 Dec
The court has agreed to hear arguments about the Biden administration's vaccine or testing requirement for large employers, and a separate vaccine mandate for healthcare workers.
25 Dec
The pandemic claimed more than 600,000 lives in Brazil. But an effective vaccination campaign has turned the tide. While the pandemic may not be causing the havoc it did in the first half of 2021, it remains a major challenge.
26 Dec
The head of the World Health Organization says rich countries are merely prolonging the pandemic by fueling vaccine inequality. "No country can boost its way out of the pandemic," he says.
25 Dec
Instead, mRNA vaccines use mRNA created in a laboratory to teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies.
23 Dec
Find these stories and much more when you grab a copy of The Guardian on Friday.⁣⁣
26 Dec
The person who died was between the ages of 60 and 79, according to the Robert Koch Institute health body. Germany has also registered a spike in omicron infections in recent days.